AI tool to detect heart amyloidosis using ultrasound
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Injuries & trauma clinical trials.
This trial tests whether artificial intelligence can help doctors spot cardiac amyloidosis (a protein buildup in the heart) using heart ultrasound images. If you have signs of a thickened heart wall and possible amyloidosis, this study could help confirm your diagnosis faster and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- Your heart's left wall is thickened (at least 12 mm thick) based on an ultrasound
- Your heart ultrasound shows warning signs that suggest you might have cardiac amyloidosis
- You do not already have a confirmed diagnosis of cardiac amyloidosis
- Your heart ultrasound images are clear enough for the AI tool to analyze
- You are willing to sign an informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an artificial-intelligence system can help decide who should get a special heart workup for a rare disease called cardiac amyloidosis. If you have signs that make doctors suspect this, the AI-guided ultrasound screening may help find it sooner.
This trial tests an AI program that looks at your heart ultrasound (echocardiogram) to find possible signs of cardiac amyloidosis early. It helps doctors decide if more testing is needed.
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
This study uses advanced heart scans and AI technology to find early signs of amyloidosis (a protein buildup in the heart) in people with atrial fibrillation. Catching it early may help prevent serious heart problems.
This study uses artificial intelligence to analyze heart ultrasounds from people hospitalized with heart failure. It aims to see if AI can help doctors better measure heart function and guide treatment.
This trial tests whether using an artificial-intelligence (AI) tool during a heart ultrasound can help guide care for people at risk for heart problems. You might benefit if you have symptoms with exercise or heart risk factors, but you do not already have known heart failure or major heart disease.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.